References
- Bird H. A., Rhind V., Leatham P., Saunders A., Wright V. Enteric-coated aspirin in rheumatoid arthritis. Rheum Rehabil 1981; 20: 116
- Bower R. J., Umbenhauer E. R., Hercus V. Clinical evaluation of sulindac: a new nonsteroidal antiinflammatory drug. Adv Inflammation Res 1979; 1: 559
- Brandslund I., Rask H., Klitgaard N. A. Gastrointestinal blood loss caused by controlled-release and conventional acetylsalicylic acid tablets. Scand J Rheumatol 1979; 8: 209
- Briggs D. F., Coutts R. T., Walter L. J. A note on the bioavailability of five Canadian brands of acetylsalicylic acid tablets. Can J Pharm Sci 1977; 12: 23
- Clark R. L., Lasagna L. How reliable are enteric-coated aspirin preparations?. Clin Pharmacol Ther 1965; 6: 568
- Hoftiezer J. W., Silvoso G. R., Burks M., Ivey K. J. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; ii: 609
- Isomäki H., Essen V.R. Magblödning förorsakad av acetylsalicylsyra–tarmlösligt preparat jämfört med ett buffrat. Läkartidningen 1975; 72: 1561
- Kahela P., Anttila M. Food and enteric-coated acetylsalicylic acid preparations. Abstracts, World Conference on Clinical Pharmacology & Therapeutics. 1980, P. Turner, C. Pudgham. Macmillan, Londo August, 1980; a. 0616: 3–9
- Kahela P., Tikkanen R., Anttila M. Pitkävaikut-teisten ja suolistoliukoisten asetyylisalisyylihappo-tablettien imeytymisvertailu. Lääkeuutiset 1979; 25: 28
- Laine V., Strandman D., Tikkanen R. Tarmlösligt acetylsalicylsyra och plasmats salicylatkoncen-tration pa morgonen. Läkartidningen 1968; 65: 3832
- Levy G. Pharmacokinetics of salicylate elimination in man. J Pharm Sci 1965; 54: 959
- Martio J. The influence of antirheumatic drugs on the occurrence of peptic ulcers. Scand J Rheumatol 1980; 9: 55
- Miller R. D. Combination use of nonsteroidal antiinflammatory drugs. Drug Intell Clin Pharm 1981; 15: 3
- Öie S., Frislid K. A fluorometric method for direct determination of plasma salicylates. Pharm ActaHelv 1971; 46: 632